Evidence map›Paper›PMID 40693275›Full record

ArticleFrontiers in pharmacology2025

Serpil Demirci Kayıran, Ömerül Faruk Tavlı, Emel Mataracı Kara, Alevcan Kaplan, Hasan Şahin, Mehmet Boğa, Esra Eroğlu Özkan

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Serpil Demirci KayıranDepartment of Pharmaceutical Botany, Faculty of Pharmacy, Çukurova University, Adana, Türkiye.
Ömerül Faruk TavlıDepartment of Pharmacognosy, Faculty of Pharmacy, Biruni University, Istanbul, Türkiye.
Emel Mataracı KaraDepartment of Pharmaceutical Microbiology, Faculty of Pharmacy, Istanbul University, Istanbul, Türkiye.
Alevcan KaplanDepartment of Crop and Animal Production, Sason Vocational School, Batman University, Batman, Türkiye.
Hasan ŞahinDepartment of Pharmacognosy, Faculty of Pharmacy, Dicle University, Diyarbakır, Türkiye.
Mehmet BoğaDepartment of Analytical Chemistry, Faculty of Pharmacy, Dicle University, Diyarbakır, Türkiye.
Esra Eroğlu ÖzkanDepartment of Pharmacognosy, Faculty of Pharmacy, Istanbul University, Istanbul, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: Plant materials were collected from distinct regions in Türkiye. Methanolic extracts were prepared and tested in vitro for antimicrobial and enzyme inhibition activities. Minimum inhibitory concentration (MIC) and IC Results: Methanolic extracts exhibited potent antifungal activity against Discussion: These findings suggest that

Indexed as

anti-aginganti-candidaanti-cholinesteraseanti-α-glucosidaseHPLCHypericum empetrifolium subsp. empetrifolium WilldLC-HR/MS

Identifiers

PMID40693275
PMCPMC12277336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.